WHO-EORTC classification for cutaneous lymphomas
Top Cited Papers
- 15 May 2005
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 105 (10), 3768-3785
- https://doi.org/10.1182/blood-2004-09-3502
Abstract
Primary cutaneous lymphomas are currently classified by the European Organization for Research and Treatment of Cancer (EORTC) classification or the World Health Organization (WHO) classification, but both systems have shortcomings. In particular, differences in the classification of cutaneous T-cell lymphomas other than mycosis fungoides, Sézary syndrome, and the group of primary cutaneous CD30+ lymphoproliferative disorders and the classification and terminology of different types of cutaneous B-cell lymphomas have resulted in considerable debate and confusion. During recent consensus meetings representatives of both systems reached agreement on a new classification, which is now called the WHO-EORTC classification. In this paper we describe the characteristic features of the different primary cutaneous lymphomas and other hematologic neoplasms frequently presenting in the skin, and discuss differences with the previous classification schemes. In addition, the relative frequency and survival data of 1905 patients with primary cutaneous lymphomas derived from Dutch and Austrian registries for primary cutaneous lymphomas are presented to illustrate the clinical significance of this new classification.Keywords
This publication has 100 references indexed in Scilit:
- Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’1British Journal of Haematology, 2004
- Cd30+ cutaneous lymphoproliferative disorders: The stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphomaJournal of the American Academy of Dermatology, 2003
- Molecular cytogenetic characterization of Sézary syndromeGenes, Chromosomes and Cancer, 2003
- Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphomaBritish Journal of Dermatology, 2002
- Co‐expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven casesJournal of Cutaneous Pathology, 2000
- Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disordersJournal of the American Academy of Dermatology, 1996
- bcl-2 Protein Expression and Correlation with the Interchromosomal 14;18 Translocation in Cutaneous Lymphomas and PseudolymphomasJournal of Investigative Dermatology, 1994
- Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic AnemiaNew England Journal of Medicine, 1989
- Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal PhotochemotherapyNew England Journal of Medicine, 1987
- Clonal T-Cell Populations in Lymphomatoid PapulosisNew England Journal of Medicine, 1986